Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
Clinical trial NCT03539952 · COMPLETED
Trial details
- NCT number
- NCT03539952
- Sponsor
- Orphalan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-03
- Primary completion
- 2020-08-19
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.